✦ LIBER ✦

Pimavanserin tartrate: a 5-HT2A inverse agonist with potential for treating various neuropsychiatric disorders

✍ Scribed by Abbas, Atheir; Roth, Bryan L

Book ID: 121258592
Publisher: Informa plc
Year: 2008
Tongue: English
Weight: 541 KB
Volume: 9
Category: Article
ISSN: 1465-6566
DOI: 10.1517/14656560802532707

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alzheimer's disease psychosis: Potential

Alzheimer's disease psychosis: Potential therapeutic benefit of pimavanserin, a 5-HT2A inverse agonist

✍ McFarland, Krista; Price, Diana L.; Gorman, Sean A.; Johnson, Robert W.; Bonhaus 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Pimavanserin tartrate, a 5-HT2A receptor

Pimavanserin tartrate, a 5-HT2A receptor inverse agonist, increases slow wave sleep as measured by polysomnography in healthy adult volunteers

✍ Sonia Ancoli-Israel; Kimberly E. Vanover; David M. Weiner; Robert E. Davis; Dani 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 328 KB

ACP-103, A 5-HT2A receptor inverse agoni

ACP-103, A 5-HT2A receptor inverse agonist, a novel potential treatment for psychosis

✍ K.E. Vanover; D.M. Weiner; S.C. Harvey; S.B. Powell; M.A. Geyer; C.M. Andersson; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 125 KB

A Novel Aminotetralin-Type Serotonin (5-

A Novel Aminotetralin-Type Serotonin (5-HT) 2C Receptor-Specific Agonist and 5-HT2A Competitive Antagonist/5-HT2B Inverse Agonist with Preclinical Efficacy for Psychoses

✍ Canal, C. E.; Morgan, D.; Felsing, D.; Kondabolu, K.; Rowland, N. E.; Robertson, 📂 Article 📅 2014 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 851 KB

Correction to "A Novel Aminotetralin-Typ

Correction to "A Novel Aminotetralin-Type Serotonin (5-HT) 2C Receptor-Specific Agonist and 5-HT2A Competitive Antagonist/5-HT2B Inverse Agonist with Preclinical Efficacy for Psychoses"

📂 Article 📅 2014 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 48 KB

ChemInform Abstract: Pyrrolo[3,2,1-ij]qu

ChemInform Abstract: Pyrrolo[3,2,1-ij]quinoline Derivatives, a 5-HT2c Receptor Agonist with Selectivity over the 5-HT2a Receptor: Potential Therapeutic Applications for Epilepsy and Obesity.

✍ Methvin Isaac; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 34 KB 👁 1 views